Company Calmare Therapeutics Inc OTC Bulletin Board
Equities
CTTC
US2045121074
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
2020 | Calmare Therapeutics Incorporated Wins $2.5 Million Federal Supply Schedule Contract | CI |
2019 | Calmare Therapeutics Incorporated Announces Board Changes | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Conrad Mir
CEO | Chief Executive Officer | 55 | 13-09-26 |
Director of Finance/CFO | 71 | - | |
Donna Mays
ADM | Chief Administrative Officer | - | - |
Stephen D'Amato
CTO | Chief Tech/Sci/R&D Officer | - | - |
William Lipford
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rustin Howard
BRD | Director/Board Member | 67 | 07-09-30 |
Conrad Mir
CEO | Chief Executive Officer | 55 | 13-09-26 |
Stanley Yarbro
BRD | Director/Board Member | 74 | - |
Peter Brennan
CHM | Chairman | 69 | 11-06-05 |
Santanu Das
BRD | Director/Board Member | - | 19-07-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,997,971 | 38,997,971 ( 100.00 %) | 0 | 99.99 % |
Stock B | 0 | 2,427 | 0 | 0 |
Company contact information
Calmare Therapeutics, Inc.
2 Trap Falls Road Suite 507
06484, Shelton
+
http://www.calmaretherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+9.40% | 222B | |
+14.74% | 195B | |
+23.75% | 148B | |
+33.88% | 113B | |
+4.18% | 66.45B | |
+13.08% | 53.11B | |
+3.16% | 50.03B | |
-4.12% | 38.8B | |
-2.44% | 34.85B |
- Stock Market
- Equities
- CTTC Stock
- CTTC Stock
- Company Calmare Therapeutics Inc